The latest news
latest news in economy
latest news in companies
Corcept Therapeutics Faces Market Selloff and Legal Probes Following FDA Rejection of Relacorilant
San Francisco, Friday, 9 January 2026.
Corcept Therapeutics (NASDAQ: CORT) is under intense pressure after the FDA issued a Complete Response Letter regarding its New Drug Application for relacorilant, a treatment for hypertension caused by hypercortisolism. The regulatory rejection, announced on December 31, 2025, precipitated a massive 50% collapse in share value, effectively erasing $3.6 billion in market capitalization. While the FDA acknowledged some positive trial data, it concluded that additional evidence is required to establish the drug’s effectiveness. Consequently, the company now faces a wave of investigations from shareholder rights law firms, including Hagens Berman and Scott+Scott. These inquiries focus on whether management overstated relacorilant’s clinical efficacy and the commercial prospects of its hypercortisolism business to investors. Analysts have subsequently downgraded price targets, casting doubt on Corcept’s ability to meet its projected revenue goals within the previously stated timeframe.
latest news in politics
DHS Identifies Portland Shooting Victims as Gang Affiliates, Igniting Federal-Local Standoff
Portland, Friday, 9 January 2026.
After agents shot two alleged Tren de Aragua members, Portland’s mayor demanded ICE halt all city operations, marking a severe escalation in federal-local jurisdictional disputes.